Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of INDV-6001 in Opioid Use Disorder
NCT06576843Phase 2Completed
- Sponsor
- Indivior
- Start
- Sep 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of INDV-6001 in opioid use disorder (OUD), sponsored by Indivior. Started Sep 2024; status: completed.
02
Drugs
INDV-6001
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06576843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06576843.